Structure |
Chemical Name |
CAS |
MF |
![Topiroxostat Impurity 46](/) |
Topiroxostat Impurity 46 |
|
|
![Topiroxostat Impurity 43](/) |
Topiroxostat Impurity 43 |
|
|
![N-(2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethyl)-N-methyl formamide](/CAS/20210111/GIF/1643948-40-6.gif) |
N-(2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethyl)-N-methyl formamide |
1643948-40-6 |
C17H25NO3 |
![Regorafenib Impurity 40](/) |
Regorafenib Impurity 40 |
|
|
![3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo-, ethyl ester](/CAS/20210111/GIF/2489671-14-7.gif) |
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo-, ethyl ester |
2489671-14-7 |
C17H18FNO5 |
![Bisoprolol Impurity 17](/CAS/20210111/GIF/109791-19-7.gif) |
Bisoprolol Impurity 17 |
109791-19-7 |
C15H23NO5 |
![Furosemide Impurity 5](/CAS/20210111/GIF/518336-22-6.gif) |
Furosemide Impurity 5 |
518336-22-6 |
C12H10ClNO3 |
![Lumateperone Impurity 2](/CAS/20210111/GIF/313544-32-0.gif) |
Lumateperone Impurity 2 |
313544-32-0 |
C16H19N3O3 |
![Pramipexole Impurity 55](/CAS/20210111/GIF/959012-83-0.gif) |
Pramipexole Impurity 55 |
959012-83-0 |
C8H11NO2 |
![INDEX NAME NOT YET ASSIGNED](/CAS/20211123/GIF/2438857-80-6.gif) |
INDEX NAME NOT YET ASSIGNED |
2438857-80-6 |
C27H22F2N6O5 |
![Nicergoline Impurity 01](/) |
Nicergoline Impurity 01 |
|
|
![impurity 38](/) |
impurity 38 |
|
|
![Benzonitrile, 4-[3-[(acetyloxy)methyl]-4-bromophenoxy]-](/CAS/20200611/GIF/2227126-09-0.gif) |
Benzonitrile, 4-[3-[(acetyloxy)methyl]-4-bromophenoxy]- |
2227126-09-0 |
C16H12BrNO3 |
![3-Pyridineacrylonitrile, α-(m-chlorophenyl)-β-hydroxy- (8CI)](/CAS/20210305/GIF/18206-80-9.gif) |
3-Pyridineacrylonitrile, α-(m-chlorophenyl)-β-hydroxy- (8CI) |
18206-80-9 |
C14H9ClN2O |
![Androsta-3,16-dien-17-ol, acetate, (5α)- (9CI)](/CAS/20211123/GIF/103088-58-0.gif) |
Androsta-3,16-dien-17-ol, acetate, (5α)- (9CI) |
103088-58-0 |
C21H30O2 |
![1-Naphthalenamine, 1,2,3,4-tetrahydro-N-methyl-4-phenyl-, (1S,4S)-](/CAS/20210111/GIF/91797-61-4.gif) |
1-Naphthalenamine, 1,2,3,4-tetrahydro-N-methyl-4-phenyl-, (1S,4S)- |
91797-61-4 |
C17H19N |
![2-Pyridineethanamine, N-methyl-N-nitroso-](/CAS/20210111/GIF/32635-81-7.gif) |
2-Pyridineethanamine, N-methyl-N-nitroso- |
32635-81-7 |
C8H11N3O |
![Peramivir Impurity 45](/) |
Peramivir Impurity 45 |
|
|
![Pentanamide, 5-(diphenylphosphinyl)-N-ethyl-](/CAS/20210111/GIF/2512198-63-7.gif) |
Pentanamide, 5-(diphenylphosphinyl)-N-ethyl- |
2512198-63-7 |
C19H24NO2P |
![1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylic acid, 2,3,6b,9,10,10a-hexahydro-, ethyl ester, (6bR,10aS)-](/CAS/20210111/GIF/313369-17-4.gif) |
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylic acid, 2,3,6b,9,10,10a-hexahydro-, ethyl ester, (6bR,10aS)- |
313369-17-4 |
C16H21N3O2 |
![Ergoline-8-methanol, 10-hydroxy-1,6-dimethyl-, 8-(5-bromo-3-pyridinecarboxylate), (8β)-](/CAS/20211123/GIF/57935-66-7.gif) |
Ergoline-8-methanol, 10-hydroxy-1,6-dimethyl-, 8-(5-bromo-3-pyridinecarboxylate), (8β)- |
57935-66-7 |
C23H24BrN3O3 |
![(5S,6S,7S)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl-1,3,4- thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2- ene-2-carboxylic acid 5-oxide](/) |
(5S,6S,7S)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl-1,3,4- thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2- ene-2-carboxylic acid 5-oxide |
|
|
![Ethanone, 2-chloro-1-[3-nitro-4-(phenylmethoxy)phenyl]-](/CAS/20210111/GIF/871266-45-4.gif) |
Ethanone, 2-chloro-1-[3-nitro-4-(phenylmethoxy)phenyl]- |
871266-45-4 |
C15H12ClNO4 |
![Cisatracurium besylate impurity11](/) |
Cisatracurium besylate impurity11 |
|
|
![(3R,5S,E)-tert-butyl 7-(4-(2-fluorophenyl)-6-isopropyl-2-(N-methyl methylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate](/) |
(3R,5S,E)-tert-butyl 7-(4-(2-fluorophenyl)-6-isopropyl-2-(N-methyl methylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate |
|
|
![Acetamide, N-?[4-?[5-?(acetylamino)?-?2-?hydroxyphenoxy]?phenyl]?-](/CAS/20211123/GIF/2575516-61-7.gif) |
Acetamide, N-?[4-?[5-?(acetylamino)?-?2-?hydroxyphenoxy]?phenyl]?- |
2575516-61-7 |
C16H16N2O4 |
![Ganciclovir EP Impurity](/) |
Ganciclovir EP Impurity |
|
|
![Crisaborole Impurity 15](/) |
Crisaborole Impurity 15 |
|
|
![Latamoxef impurity A](/) |
Latamoxef impurity A |
|
|
![Cefadroxil Impurity C](/CAS/20210305/GIF/79962-91-7.gif) |
Cefadroxil Impurity C |
79962-91-7 |
C16H17N3O5S |
![Pralatrexate Impurity 8](/CAS/20210111/GIF/112408-16-9.gif) |
Pralatrexate Impurity 8 |
112408-16-9 |
C8H15NO4 |
![Pitavastatin Impurity 46](/) |
Pitavastatin Impurity 46 |
|
|
![Canagliflozin Impurity 46](/) |
Canagliflozin Impurity 46 |
|
|
![Lenvatinib Impurity 37](/) |
Lenvatinib Impurity 37 |
|
|
![Sitafloxacin Impurity 20](/) |
Sitafloxacin Impurity 20 |
|
|
![posaconazole impurity 66](/) |
posaconazole impurity 66 |
|
|
![Dapoxetine impurity 33](/) |
Dapoxetine impurity 33 |
|
|
![Budesonide Impurity 4](/) |
Budesonide Impurity 4 |
|
|
![Canagliflozin Impurity 49](/CAS/20211123/GIF/2243132-56-9.gif) |
Canagliflozin Impurity 49 |
2243132-56-9 |
C34H35FO11S |
![Canagliflozin Impurity 55](/) |
Canagliflozin Impurity 55 |
|
|
![Rosuvastatin Impurity 74](/) |
Rosuvastatin Impurity 74 |
|
|
![Tofacitinib Impurity 106](/) |
Tofacitinib Impurity 106 |
|
|
![Hydroxychloroquine Impurity J](/) |
Hydroxychloroquine Impurity J |
|
|
![Levetiracetam Impurity 25](/) |
Levetiracetam Impurity 25 |
|
|
![Levosimendan Impurity 7](/) |
Levosimendan Impurity 7 |
|
|
![Cabozantinib impurity K](/) |
Cabozantinib impurity K |
|
|
![Crisaborole Impurity 8](/) |
Crisaborole Impurity 8 |
|
|
![Trifluridine Impurity B](/) |
Trifluridine Impurity B |
|
|
![Rotigotine Impurity](/) |
Rotigotine Impurity |
|
|
![Olprinone Impurity 2](/CAS/20210111/GIF/106730-62-5.gif) |
Olprinone Impurity 2 |
106730-62-5 |
C14H12N4O2 |
![Nicorandil Impurity F](/) |
Nicorandil Impurity F |
|
|
![Nicorandil Impurity A](/) |
Nicorandil Impurity A |
|
|
![Evogliptin Impurity 1](/) |
Evogliptin Impurity 1 |
|
|
![Ondansetron IMpurity 5](/) |
Ondansetron IMpurity 5 |
|
|
![(E)-methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate](/) |
(E)-methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
|
![2-フルオロ-4-アセチル-1,1'-ビフェニル](/CAS/GIF/42771-79-9.gif) |
2-フルオロ-4-アセチル-1,1'-ビフェニル |
42771-79-9 |
C14H11FO |
![4-ヒドロキシベンゼン-1,3-ジメタノール](/CAS/GIF/2937-60-2.gif) |
4-ヒドロキシベンゼン-1,3-ジメタノール |
2937-60-2 |
C8H10O3 |
![Oseltamivir Impurity 107](/) |
Oseltamivir Impurity 107 |
|
|
![Oseltamivir Impurity 66](/) |
Oseltamivir Impurity 66 |
|
|
![Dapagliflozin Impurity 46](/) |
Dapagliflozin Impurity 46 |
|
|
![Brexpiprazole Impurity ABCDEFGHJKL](/) |
Brexpiprazole Impurity ABCDEFGHJKL |
|
|
![4,4'-(2-ピリジニルメチレン)ビスフェノール](/CAS/GIF/603-41-8.gif) |
4,4'-(2-ピリジニルメチレン)ビスフェノール |
603-41-8 |
C18H15NO2 |
![Tazobactam Impurity DBT](/) |
Tazobactam Impurity DBT |
|
|
![3β-[4-O-[4-O-(2,6-ジデオキシ-β-D-ribo-ヘキソピラノシル)-2,6-ジデオキシ-β-D-ribo-ヘキソピラノシル]-2,6-ジデオキシ-β-D-ribo-ヘキソピラノシルオキシ]-12β,14,16β-トリヒドロキシ-5β-カルダ-20(22)-エノリド](/CAS/20180808/GIF/52589-12-5.gif) |
3β-[4-O-[4-O-(2,6-ジデオキシ-β-D-ribo-ヘキソピラノシル)-2,6-ジデオキシ-β-D-ribo-ヘキソピラノシル]-2,6-ジデオキシ-β-D-ribo-ヘキソピラノシルオキシ]-12β,14,16β-トリヒドロキシ-5β-カルダ-20(22)-エノリド |
52589-12-5 |
C41H64O15 |
![Thiophene, 2-(2-fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]-](/CAS/20210305/GIF/2436275-33-9.gif) |
Thiophene, 2-(2-fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]- |
2436275-33-9 |
C18H14FIS |
![Revefenacin Impurity 2](/CAS/20210305/GIF/1158699-78-5.gif) |
Revefenacin Impurity 2 |
1158699-78-5 |
C14H17NO4 |
![(R)-2-(4-Methoxyphenyl)-1-methylethanamine](/CAS/GIF/58993-79-6.gif) |
(R)-2-(4-Methoxyphenyl)-1-methylethanamine |
58993-79-6 |
C10H15NO |
![N-[5-[(1RS)-2-[benzyl[(1RS)-2-(4-methoxyphenyl)- 1-methylethyl]amino]-1-hydroxyethyl]-2- hydroxyphenyl]formamide](/CAS/20210305/GIF/2514947-17-0.gif) |
N-[5-[(1RS)-2-[benzyl[(1RS)-2-(4-methoxyphenyl)- 1-methylethyl]amino]-1-hydroxyethyl]-2- hydroxyphenyl]formamide |
2514947-17-0 |
C26H30N2O4 |
![NA](/) |
NA |
|
|
![Cilastatin Impurity H](/) |
Cilastatin Impurity H |
|
|
![(trans, trans)-3,3'-(1,4,7,10-tetraazacyclododecane-1,7-diyl)bis(butane-1,2,4-triol)](/) |
(trans, trans)-3,3'-(1,4,7,10-tetraazacyclododecane-1,7-diyl)bis(butane-1,2,4-triol) |
|
|
![Azelastine Impurity K](/) |
Azelastine Impurity K |
|
|
![(4R,6R)-6-(2-((1S,2S)-2,6-dimethyl-1,2,3,4-tetrahydronaphthalen-1-](/) |
(4R,6R)-6-(2-((1S,2S)-2,6-dimethyl-1,2,3,4-tetrahydronaphthalen-1- |
|
|
![Carbazochrome Sodium Sulfonate Impurity 1](/) |
Carbazochrome Sodium Sulfonate Impurity 1 |
|
|
![Rosuvastatin Impurity 147](/) |
Rosuvastatin Impurity 147 |
|
|
![NA](/) |
NA |
|
|
![Cetrorelix Impurity 10](/) |
Cetrorelix Impurity 10 |
|
|
![Cetrorelix Impurity 3 (9-D-Pro)](/) |
Cetrorelix Impurity 3 (9-D-Pro) |
|
|
![2-アミノ-N-[(1α,4β)-4-ヒドロキシシクロヘキシル]ベンズアミド](/CAS/GIF/15942-11-7.gif) |
2-アミノ-N-[(1α,4β)-4-ヒドロキシシクロヘキシル]ベンズアミド |
15942-11-7 |
C13H18N2O2 |
![4-O-(カルボキシメチル)リファマイシン](/CAS/GIF/13929-35-6.gif) |
4-O-(カルボキシメチル)リファマイシン |
13929-35-6 |
C39H49NO14 |
![ethyl 3,5-bis(benzyloxy)benzoate](/CAS/GIF/50841-46-8.gif) |
ethyl 3,5-bis(benzyloxy)benzoate |
50841-46-8 |
C23H22O4 |
![(R)-4α-チアゾリジンカルボン酸エチル](/CAS/GIF/60664-15-5.gif) |
(R)-4α-チアゾリジンカルボン酸エチル |
60664-15-5 |
C6H11NO2S |
![3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl) amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile](/CAS/20211123/GIF/2504210-48-2.gif) |
3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl) amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile |
2504210-48-2 |
C22H23N9O |
![Faropenem Impurity D](/) |
Faropenem Impurity D |
|
|
![6β-ブロモペニシラン酸](/CAS/GIF/24138-28-1.gif) |
6β-ブロモペニシラン酸 |
24138-28-1 |
C8H10BrNO3S |
![5-ニトロ-2-フランカルボアルデヒド(5-ニトロ-2-フラニル)メチレンヒドラゾン](/CAS/GIF/736-53-8.gif) |
5-ニトロ-2-フランカルボアルデヒド(5-ニトロ-2-フラニル)メチレンヒドラゾン |
736-53-8 |
C10H6N4O6 |
![4-(benzo[b]thiophen-4-yl)-1,1-bis(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)piperazin-1-ium chloride](/CAS/20211123/GIF/2454317-16-7.gif) |
4-(benzo[b]thiophen-4-yl)-1,1-bis(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)piperazin-1-ium chloride |
2454317-16-7 |
C38H41N4O4S |
![(R)-4-チアゾリジンカルボン酸メチル](/CAS/GIF/42258-90-2.gif) |
(R)-4-チアゾリジンカルボン酸メチル |
42258-90-2 |
C5H9NO2S |
![Revefenacin Impurity 7](/CAS/20211123/GIF/1158777-54-8.gif) |
Revefenacin Impurity 7 |
1158777-54-8 |
C14H19ClN2O3 |
![(R)-8-(3-aminopiperidin-1-yl)-3-methyl-1,7-bis((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione](/) |
(R)-8-(3-aminopiperidin-1-yl)-3-methyl-1,7-bis((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione |
|
|
![Oxytocin Impurity 8 Trifluoroacetate](/) |
Oxytocin Impurity 8 Trifluoroacetate |
|
|
![Plerixafor Impurity 1](/) |
Plerixafor Impurity 1 |
|
|
![MeropeneM iMpurity 7](/) |
MeropeneM iMpurity 7 |
|
|
![Brexpiprazole Impurity 34](/CAS/20200515/GIF/2247155-42-4.gif) |
Brexpiprazole Impurity 34 |
2247155-42-4 |
C25H27N3O4S |
![Cabozantinib Impurity 5](/CAS/20210111/GIF/104330-60-1.gif) |
Cabozantinib Impurity 5 |
104330-60-1 |
C11H12FNO3 |
![Dronedarone Impurity 9](/) |
Dronedarone Impurity 9 |
|
|
![Empagliflozin Impurity 58](/) |
Empagliflozin Impurity 58 |
|
|
![Exemestane Impurity 6](/) |
Exemestane Impurity 6 |
14895-71-7 |
|
![Gadobutrol Impurity 10](/) |
Gadobutrol Impurity 10 |
|
|
![Linagliptin Impurity 55](/) |
Linagliptin Impurity 55 |
|
|